Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

NOUVELLE PHARMACIE DU STADE TRIOLO : revenue, balance sheet and financial ratios

NOUVELLE PHARMACIE DU STADE TRIOLO is a French company founded 6 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in VILLENEUVE-D'ASCQ (59650), this company of category PME shows in 2022 a revenue of 1.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - NOUVELLE PHARMACIE DU STADE TRIOLO (SIREN 879471472)
Indicator 2024 2023 2022 2021 2020
Revenue N/C N/C 1 492 042 € N/C N/C
Net income 65 299 € 67 719 € 107 230 € 121 384 € 90 519 €
EBITDA N/C N/C 174 885 € N/C N/C
Net margin N/C N/C 7.2% N/C N/C

Revenue and income statement

In 2024, NOUVELLE PHARMACIE DU STADE TRIOLO generates positive net income of 65 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2024: 91 k€ -> 65 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

65 299 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 112%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 43%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

112.206%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

42.773%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

55.9%

Solvency indicators evolution
NOUVELLE PHARMACIE DU STADE TRIOLO

Sector positioning

Debt ratio
112.21 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of NOUVELLE PHARMACIE DU STA... (112.21) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
42.77% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average +6 pts over 3 years

In 2024, the financial autonomy of NOUVELLE PHARMACIE DU STA... (42.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
6.01 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average

In 2022, the repayment capacity of NOUVELLE PHARMACIE DU STA... (6.01) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 147.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

147.847

Liquidity indicators evolution
NOUVELLE PHARMACIE DU STADE TRIOLO

Sector positioning

Liquidity ratio
147.85 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average -16 pts over 3 years

In 2024, the liquidity ratio of NOUVELLE PHARMACIE DU STA... (147.85) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
3.35x 2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Good

In 2022, the interest coverage of NOUVELLE PHARMACIE DU STA... (3.4x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
NOUVELLE PHARMACIE DU STADE TRIOLO

Positioning of NOUVELLE PHARMACIE DU STADE TRIOLO in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of NOUVELLE PHARMACIE DU STADE TRIOLO is estimated at 911 622 € (range 634 839€ - 1 363 839€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
634k€ 911k€ 1363k€
911 622 € Range: 634 839€ - 1 363 839€
NAF 5 année 2024

Valuation method used

Net Income Multiple
65 299 € × 14.0x = 911 622 €
Range: 634 839€ - 1 363 839€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare NOUVELLE PHARMACIE DU STADE TRIOLO with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about NOUVELLE PHARMACIE DU STADE TRIOLO

What is the revenue of NOUVELLE PHARMACIE DU STADE TRIOLO ?

The revenue of NOUVELLE PHARMACIE DU STADE TRIOLO in 2022 is 1.5 M€.

Is NOUVELLE PHARMACIE DU STADE TRIOLO profitable?

Yes, NOUVELLE PHARMACIE DU STADE TRIOLO generated a net profit of 65 k€ in 2024.

Where is the headquarters of NOUVELLE PHARMACIE DU STADE TRIOLO ?

The headquarters of NOUVELLE PHARMACIE DU STADE TRIOLO is located in VILLENEUVE-D'ASCQ (59650), in the department Nord.

Where to find the tax return of NOUVELLE PHARMACIE DU STADE TRIOLO ?

The tax return of NOUVELLE PHARMACIE DU STADE TRIOLO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does NOUVELLE PHARMACIE DU STADE TRIOLO operate?

NOUVELLE PHARMACIE DU STADE TRIOLO operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.